title: [Coefficient of linear correlation between levels of fibrinogen, antithrombin III, thrombin-antithrombin complex and lipid fractions in women exposed chronically to carbon disulfide].
abstract: The authors examined 65 women, aged 22-58 years. They were derived from two industrial populations of different production profiles, and divided into three groups. Group I--the control group--was composed of 20 women, mean age 44.5 +/- 12.02 years, employed in the DANA Enterprise, Szczecin, not exposed to carbon disulfide; Group II--the group studied--comprised 22 women, mean age 42.5 +/- 4.95 years, employed in the WISKORD Enterprise, Szczecin, chronically exposed to carbon disulfide at the concentration of 9.36-23.4 mg/m2; and Group III--included 23 women, mean age 46.7 +/- 8.81 years, suffering from diabetes mellitus II. The study reveals that carbon disulfide exerts significant adverse effect on plasma lipid fractions, and induces changes in the coagulation system, creating the risk of ischaemic diseases.
authors.affiliation: Samodzielnej Pracowni Menopauzy i Andropauzy, Pomorskiej Akademii Medycznej w Szczecinie.
authors.forename: S
authors.initials: S
authors.lastname: Stanosz
authors.forename: E
authors.initials: E
authors.lastname: Kuligowska
authors.forename: D
authors.initials: D
authors.lastname: Kuligowski
mesh_terms: D000328:Adult; D000990:Antithrombin III / Q000032:analysis*; D001777:Blood Coagulation; D002246:Carbon Disulfide / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004781:Environmental Exposure / Q000009:adverse effects*; D004784:Environmental Monitoring; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D016014:Linear Models; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D016273:Occupational Exposure / Q000009:adverse effects; D012307:Risk Factors
chemical_list: D008055:Lipids; D000990:Antithrombin III; D005340:Fibrinogen; D002246:Carbon Disulfide
vernacular_title: Współczynniki korelacji liniowej miedzy stezeniami fibrynogenu, antytrombiny III, kompleksów trombina-antytrombina a frakcjami lipidowymi u kobiet narazonych na przewlekłe działanie dwusiarczku wegla.